Literature DB >> 18462686

Structural plasticity underpins promiscuous binding of the prosurvival protein A1.

Callum Smits1, Peter E Czabotar, Mark G Hinds, Catherine L Day.   

Abstract

Apoptotic pathways are regulated by protein-protein interactions. Interaction of the BH3 domains of proapoptotic Bcl-2 family proteins with the hydrophobic groove of prosurvival proteins is critical. Whereas some BH3 domains bind in a promiscuous manner, others exhibit considerable selectivity and the sequence characteristics that distinguish these activities are unclear. In this study, crystal structures of complexes between the prosurvival protein A1 and the BH3 domains from Puma, Bmf, Bak, and Bid have been solved. The structure of A1 is similar to that of other prosurvival proteins, although features, such as an acidic patch in the binding groove, may allow specific therapeutic modulation of apoptosis. Significant conformational plasticity was observed in the intermolecular interactions and these differences explain some of the variation in affinity. This study, in combination with published data, suggests that interactions between conserved residues demarcate optimal binding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462686     DOI: 10.1016/j.str.2008.02.009

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  51 in total

Review 1.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.

Authors:  Bonsu Ku; Chengyu Liang; Jae U Jung; Byung-Ha Oh
Journal:  Cell Res       Date:  2010-11-09       Impact factor: 25.617

3.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

Review 4.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

5.  α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.

Authors:  James W Checco; Erinna F Lee; Marco Evangelista; Nerida J Sleebs; Kelly Rogers; Anne Pettikiriarachchi; Nadia J Kershaw; Geoffrey A Eddinger; David G Belair; Julia L Wilson; Chelcie H Eller; Ronald T Raines; William L Murphy; Brian J Smith; Samuel H Gellman; W Douglas Fairlie
Journal:  J Am Chem Soc       Date:  2015-08-28       Impact factor: 15.419

Review 6.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

Review 7.  Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.

Authors:  D Westphal; R M Kluck; G Dewson
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

8.  Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.

Authors:  Emiko Fire; Stefano V Gullá; Robert A Grant; Amy E Keating
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

Review 9.  Death on the slopes. Symposium on Cell Death Pathways.

Authors:  Christina K McPhee; Jahda H Hill; Mari Enoksson
Journal:  EMBO Rep       Date:  2009-07-17       Impact factor: 8.807

10.  Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes.

Authors:  Erinna F Lee; Oliver B Clarke; Marco Evangelista; Zhiping Feng; Terence P Speed; Elissaveta B Tchoubrieva; Andreas Strasser; Bernd H Kalinna; Peter M Colman; W Douglas Fairlie
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.